By Marie Rosenthal, MS
The commonly used antibiotic azithromycin is not linked to an increased risk for ventricular arrhythmia. Rather the adverse event is more likely due to infection or patient characteristics, according to a large study (CMAJ 2017 Apr 18. [Epub ahead of print]).
“Using an incredibly large and robust population and strong methods they show that the risk associated with azithromycin, a QTc interval–prolonging agent, is no higher than amoxicillin, a non–QTc